Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension

Pulmonary Circulation

Volumn 7, Issue 2, 2017, Pages 399-408

  Medrek, Sarah K ^a   Kloefkorn, Chad ^a   Nguyen, Duc T M ^b   Graviss, Edward A ^b   Frost, Adaani E ^b,c   Safdar, Zeenat ^b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Pulmonary arterial capacitance; Pulmonary arterial hypertension

Indexed keywords

AGED; ARTICLE; BLOOD VESSEL CAPACITANCE; CLINICAL OUTCOME; FEMALE; FUNCTIONAL STATUS; HEART CATHETERIZATION; HUMAN; LONGITUDINAL STUDY; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PREDICTIVE VALUE; PROGNOSTIC ASSESSMENT; PULMONARY ARTERIAL CAPACITANCE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SURVIVAL; TRANSPLANT FREE SURVIVAL; TREND STUDY;

EID: 85021280036     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.1177/2045893217698715     Document Type: Article

References (42)

1. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46(4): 903–975.
2. Benza RL, Miller DP, Barst RJ, et al. An evaluation of longterm survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012; 142(2): 448–456.
3. McLaughlin VV, Gaine SP, Howard LS, et al. Treatment goals of pulmonary hypertension. J Am Coll Cardiol 2013; 62(25 Suppl): D73–81.
4. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122(2): 164–172.
5. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122(2): 156–163.
6. Tan W, Madhavan K, Hunter KS, et al. Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). Pulm Circ 2014; 4(4): 560–580.
7. Thenappan T, Prins KW, Pritzker MR, et al. The critical role of pulmonary arterial compliance in pulmonary hypertension. Ann Am Thorac Soc 2016; 13(2): 276–284.
8. Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012; 308(9): 875–881.
9. Mahapatra S, Nishimura RA, Sorajja P, et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006; 47(4): 799–803.
10. Gan CT, Lankhaar JW, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007; 132(6): 1906–1912.
11. Rodes-Cabau J, Domingo E, Roman A, et al. Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart 2003; 89(3): 311–315.
12. de Perrot M, McRae K, Shargall Y, et al. Early postoperative pulmonary vascular compliance predicts outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Chest 2011; 140(1): 34–41.
13. Hilde JM, Skjorten I, Hansteen V, et al. Haemodynamic responses to exercise in patients with COPD. Eur Respir J 2013; 41(5): 1031–1041.
14. Bandara M, Gordon FD, Sarwar A, et al. Successful outcomes following living donor liver transplantation for portopulmonary hypertension. Liver Transpl 2010; 16(8): 983–989.
15. Inuzuka R, Seki M, Sugimoto M, et al. Pulmonary arterial wall stiffness and its impact on right ventricular afterload in patients with repaired tetralogy of Fallot. Ann Thorac Surg 2013; 96(4): 1435–1441.
16. Al-Naamani N, Preston IR, Paulus JK, et al. Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction. JACC Heart Fail 2015; 3(6): 467–474.
17. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62(25 Suppl): D34–41.
18. Morine KJ, Kiernan MS, Pham DT, et al. Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery. J Card Fail 2016; 22(2): 110–116.
19. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986; 73(3): 751–754.
20. Stevens GR, Garcia-Alvarez A, Sahni S, et al. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging 2012; 5(4): 378–387.
21. Dawes TJ, Gandhi A, de Marvao A, et al. Pulmonary artery stiffness is independently associated with right ventricular mass and function: a cardiac MR imaging study. Radiology 2016; 280(2): 398–404.
22. Kawut SM, Barr RG, Lima JA, et al. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: the Multi-Ethnic Study of Atherosclerosis (MESA)–right ventricle study. Circulation 2012; 126(14): 1681–1688.
23. Brittain EL, Pugh ME, Wheeler LA, et al. Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. JACC Heart Fail 2013; 1(4): 300–307.
24. Nickel N, Golpon H, Greer M, et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 39(3): 589–596.
25. Ventetuolo CE, Gabler NB, Fritz JS, et al. Are hemodynamics surrogate end points in pulmonary arterial hypertension? Circulation 2014; 130(9): 768–775.
26. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40(4): 780–788.
27. van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58(24): 2511–2519.
28. Lankhaar JW, Westerhof N, Faes TJ, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 2006; 291(4): H1731–1737.
29. Lankhaar JW, Westerhof N, Faes TJ, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008; 29(13): 1688–1695.
30. Tedford RJ, Hassoun PM, Mathai SC, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012; 125(2): 289–297.
31. Saouti N, Westerhof N, Helderman F, et al. RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009; 297(6): H2154–2160.
32. MacKenzie Ross RV, Toshner MR, Soon E, et al. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2013; 305(2): H259–264.
33. Hadinnapola C, Li Q, Su L, et al. The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease. Physiol Rep 2015; 3(4): e12363.
34. Tian L and Chesler NC. In vivo and in vitro measurements of pulmonary arterial stiffness: A brief review. Pulm Circ 2012; 2(4): 505–517.
35. Mahapatra S, Nishimura RA, Oh JK, et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr 2006; 19(8): 1045–1050.
36. Dyer K, Lanning C, Das B, et al. Noninvasive Doppler tissue measurement of pulmonary artery compliance in children with pulmonary hypertension. J Am Soc Echocardiogr 2006; 19(4): 403–412.
37. Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging 2009; 2(3): 286–295.
38. Kang KW, Chang HJ, Kim YJ, et al. Cardiac magnetic resonance imaging-derived pulmonary artery distensibility index correlates with pulmonary artery stiffness and predicts functional capacity in patients with pulmonary arterial hypertension. Circ J 2011; 75(9): 2244–2251.
39. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28(10): 1250–1257.
40. Sachdev A, Villarraga HR, Frantz RP, et al. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 2011; 139(6): 1299–1309.
41. Mauritz GJ, Kind T, Marcus JT, et al. Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension. Chest 2012; 141(4): 935–943.
42. Hardegree EL, Sachdev A, Villarraga HR, et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol 2013; 111(1): 143–148.